Mr angiograph head w/o&w/dye
CPT code 70546 is for an MR angiography (MRA) of the head performed twice—once without contrast dye and again with contrast dye injected into the bloodstream. This imaging study visualizes blood vessels in the brain to detect aneurysms, blockages, or vascular abnormalities.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Document medical necessity for dual-phase imaging explicitly—specify why both non-contrast and contrast phases were clinically required
Impact: Prevents downcoding to 70544 (without contrast only) or 70545 (with contrast only), preserving the full $324.76 reimbursement versus $267-$296 for single-phase studies
Verify contrast type and dosage documentation—gadolinium-based contrast agent name, dose, and route must be documented
Impact: Missing contrast documentation triggers automatic denials or downcoding to 70544, resulting in $30-60 underpayment per claim
Confirm that imaging sequences for both phases are distinctly documented in the radiology report with separate interpretations
Impact: Auditors look for evidence of both acquisitions; vague documentation risks recoupment of 15-20% of payments during post-payment audits
Do not bill 70546 with 70544 or 70545 for the same anatomical region on the same date—70546 is the comprehensive code
Impact: Prevents unbundling denials and potential fraud allegations; CCI edits will deny the separate codes with 100% payment loss
For bilateral imaging or multiple vascular territories, confirm the anatomical coverage matches 'head' definition—circle of Willis, intracranial vessels
Impact: Incorrect anatomical assignment (e.g., using head code for neck vessels) causes denials requiring extensive appeals and 4-8 week payment delays
Check patient renal function documentation before contrast administration and document GFR or creatinine levels
Impact: Lack of renal function screening increases medical liability and can trigger quality metric failures affecting facility accreditation and payer contracts
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.